Brief: Integragen announces positive results of two miR-31-3p biomarker studies
01/06/2015 17:17
June 1 (Reuters) - Integragen SA ALINT.PA :
* Announces at ASCO positive results of two new studies on
the role of miR-31-3p biomarker in patients with metastatic
colorectal cancer
* Results confirm that expression of miR-31-3p is associated
with survival and response to anti-EGFR therapies in patients
with metastatic colorectal cancer and pave the way to a
provision of the test to clinicians
Source text: http://bit.ly/1Jk7HI9
Further company coverage: ALINT.PA
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 3920;))